Cancer Is Serious Business

Subscribe to the Burzynski Documentary Series mailing list.

* indicates required

Email Address *

BURZYNSKI

1

2

About Burzynski: PART I

The first in the series, "Burzynski, the Movie," is an internationally award-winning documentary originally released in 2010 (with an Extended Edition released in 2011) that tells the true story of a medical doctor and Ph.D biochemist named Dr. Stanislaw Burzynski who won the largest, and possibly the most convoluted and intriguing legal battle against the Food & Drug Administration in American history.

His victorious battles with the United States government were centered around Dr. Burzynski's gene-targeted cancer medicines he discovered in the 1970's called Antineoplastons, which have currently completed Phase II FDA-supervised clinical trials in 2009 and has been given permission by the FDA to begin the final phase of FDA testing–randomized controlled clinical trials. .

When Antineoplastons are approved, it will mark the first time in history a single scientist, not a pharmaceutical company, will hold the exclusive patent and distribution rights on a paradigm-shifting medical breakthrough.

About Burzynski: PART II

In the compelling follow-up to the first internationally award-winning documentary, “Burzynski: Cancer is Serious Business, Part II” explores the current status of Antineoplastons' clinical testing sanctioned by the United States Food & Drug Administration—and features a modern story of the struggling journeys of cancer patients being treated today at the Burzynski Clinic in Houston, Texas.

For most patients undergoing Burzynski's treatment, their advanced cancer itself runs secondary to the constant barrage of skepticism coming not only from their local oncologists, but also from friends and family who feel their loved ones are making suspect treatment decisions—even though mainstream oncology has already left many for dead.

As the story unfolds, it reveals a real-time change of hearts and minds from many of these doctors and families and with candid interviews with board-certified oncologists, surgeons and neurosurgeons.

From Our Blog

Since Burzynski defeated the Food and Drug Administration in the 1990s, they were obligated to open up FDA-authorized clinical trials treating patients with Antineoplastons.

Since many of his patients at the time suffered from inoperable brain cancer, most of his Antineoplaston clinical data was in this realm, thus justifying a series of Phase II clinical trials to treat a myriad of different brain cancers. Without the obstruction of FDA red tape, The Burzynski Clinic would gladly treat anyone with most all cancer types if they were allowed to.

Many of the Phase II clinical trials are now complete, and published in the peer-reviewed literature.

Disclaimer

This documentary project is one of investigative journalism. The producers of this project have no direct affiliation with Dr. Burzynski, The Burzynski Clinic, or The Burzynski Research Institute, Inc.

Please contact The Burzynski Clinic directly for any services offered by The Burzynski Clinic, or call: 713-335-5697.